Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Filings indexed 844 across all filing types
Latest filing 2008-08-07 Director's Dealing
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Final Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's cessation date and states 'NIL' for securities held, indicating it is a notice of a director's personal share transactions or interests. The document is short (2340 characters) and contains no financial statements or company performance data. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or interests of company directors. Therefore, the correct classification is DIRS.
2008-08-07 English
Resignation Of Directors 1 page ?Kb
Board/Management Information Classification · 100% confidence The document is a short announcement dated 8 August 2008 from Probiomics Limited regarding the resignation of two non-executive directors from the board. It contains no financial data, no report or presentation, and no mention of voting results or other regulatory filings. The content clearly relates to changes in the company's board of directors. The document length is only 1122 characters, indicating it is a brief announcement rather than a detailed report. Therefore, the appropriate classification is Board/Management Information (MANG).
2008-08-07 English
Final Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including unlisted options, and the date the director ceased to be a director. This is a report of personal share transactions or holdings by a company director, which fits the definition of Director's Dealing filings. The document length is short and focused solely on director interests, with no financial performance or other report content. Therefore, the appropriate classification is Director's Dealing (DIRS).
2008-08-06 English
Initial Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, with all entries marked as NIL. This is a report of personal share transactions or interests by a company director. The document length is short and focused solely on director's interests, matching the definition of Director's Dealing filings. Therefore, the appropriate classification is DIRS (Director's Dealing).
2008-08-05 English
Final Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including unlisted options, and notes the date the director ceased to be a director. The content is focused on disclosure of personal share transactions or holdings by a company director. There is no financial performance data, audit information, or report publication. The document is a regulatory filing related to director's share interests, which aligns with the category 'Director's Dealing' (DIRS). The document length is short and specific to director interests, confirming the classification as DIRS with high confidence.
2008-08-05 English
Initial Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, with all entries marked as NIL. This type of document is a report of personal share transactions or interests by company directors. It matches the definition of 'Director's Dealing' filings, which report personal share transactions or interests by company directors and executives. The document length is short and contains no financial data or report content, confirming it is not a financial report or announcement but a director's dealing notice.
2008-08-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.